R John Fletcher Clear Point Neuro, Inc. (CLPT) insider trading activity

CLPT Quotes by TradingView

R John Fletcher is Director of ClearPoint Neuro, Inc.. Currently has a direct ownership of 91,950 shares of CLPT, which is worth approximately $495,610. The most recent transaction as insider was on May 14, 2024, when has been sold 17,153 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K
24.35% 3M change
29.24% 12M change
Total Value Held $495,610

R JOHN FLETCHER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 14 2024
BUY
Exercise of conversion of derivative security
-
17,153 Added 15.72%
91,950 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
$5,780 $6.8 p/Share
850 Added 1.12%
74,797 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
$5,778 $6.79 p/Share
851 Added 1.14%
73,947 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
$5,776 $5.01 p/Share
1,153 Added 1.55%
73,096 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
$5,777 $7.24 p/Share
798 Added 1.1%
71,943 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
$5,772 $8.44 p/Share
684 Added 0.95%
71,145 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
$17,334 $7.97 p/Share
2,175 Added 2.99%
70,461 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
$17,343 $10.19 p/Share
1,702 Added 2.43%
68,286 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
$17,341 $12.63 p/Share
1,373 Added 2.02%
66,584 Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
9,269 Added 12.44%
65,211 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
$17,340 $9.96 p/Share
1,741 Added 3.02%
55,942 Common Stock
Jan 01 2022
BUY
Grant, award, or other acquisition
$23,115 $11.54 p/Share
2,003 Added 3.56%
54,201 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
$23,117 $17.92 p/Share
1,290 Added 2.41%
52,198 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$15,620 $20.26 p/Share
771 Added 1.49%
50,908 Common Stock
Jun 25 2021
BUY
Grant, award, or other acquisition
-
3,003 Added 5.65%
50,137 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
$14,443 $19.57 p/Share
738 Added 1.54%
47,134 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$12,120 $15.0 p/Share
808 Added 1.71%
46,396 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$12,128 $5.71 p/Share
2,124 Added 4.45%
45,588 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$12,128 $5.71 p/Share
2,124 Added 4.45%
45,588 Common Stock

Also insider at

KRMD
KORU Medical Systems, Inc. Healthcare
Director
ACLS
AXCELIS TECHNOLOGIES INC Technology
Director
VYNT
Vyant Bio, Inc. Healthcare
Director
OPTN
OptiNose, Inc. Healthcare
Director
RJF

R John Fletcher

Director
Cherry Hill,, NJ

Track Institutional and Insider Activities on CLPT

Follow ClearPoint Neuro, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLPT shares.

Notify only if

Insider Trading

Get notified when an Clear Point Neuro, Inc. insider buys or sells CLPT shares.

Notify only if

News

Receive news related to ClearPoint Neuro, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLPT